About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2011 (2011), Article ID 294968, 9 pages
Review Article

Mechanisms That Regulate Peripheral Immune Responses to Control Organ-Specific Autoimmunity

School of Health Sciences, University of Notre Dame Australia, 19 Mouat Street, Fremantle, WA 6959, Australia

Received 16 January 2011; Accepted 16 February 2011

Academic Editor: Aziz Alami Chentoufi

Copyright © 2011 Gerard F. Hoyne. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [11 citations]

The following is the list of published articles that have cited the current article.

  • B. Brooks-Worrell, and J. P. Palmer, “Immunology in the Clinic Review Series; focus on metabolic diseases: development of islet autoimmune disease in type 2 diabetes patients: potential sequelae of chronic inflammation,” Clinical & Experimental Immunology, vol. 167, no. 1, pp. 40–46, 2011. View at Publisher · View at Google Scholar
  • Edmond M. Linossi, and Sandra E. Nicholson, “The SOCS boxuAdapting proteins for ubiquitination and proteasomal degradation,” Iubmb Life, vol. 64, no. 4, pp. 316–323, 2012. View at Publisher · View at Google Scholar
  • Pearlie K Epling-Burnette, Jessica McDaniel, Sheng Wei, and Alan F List, “Emerging immunosuppressive drugs in myelodysplastic syndromes,” Expert Opinion on Emerging Drugs, vol. 17, no. 4, pp. 519–541, 2012. View at Publisher · View at Google Scholar
  • Miriam B. Torchinsky, J. Magarian Blander, and Laura Campisi, “Revisiting the old link between infection and autoimmune disease with commensals and T helper 17 cells,” Immunologic Research, vol. 54, no. 1-3, pp. 50–68, 2012. View at Publisher · View at Google Scholar
  • Sinyi Kong, Pricilla Yeung, and Deyu Fang, “The Class III Histone Deacetylase Sirtuin 1 in Immune Suppression and Its Therapeutic Potential in Rheumatoid Arthritis,” Journal of Genetics and Genomics, 2013. View at Publisher · View at Google Scholar
  • Marius Strioga, Virgil Schijns, Daniel J. Powell, Vita Pasukoniene, Neringa Dobrovolskiene, and Jaroslav Michalek, “Dendritic cells and their role in tumor immunosurveillance,” Innate Immunity, vol. 19, no. 1, pp. 98–111, 2013. View at Publisher · View at Google Scholar
  • Ferjani Zouidi, Mouna Stayoussef, Dorra Bouzid, Hajer Fourati, Olfa Abida, M. Ben Ayed, Thouraya Kammoun, Monjia Hachicha, Carlos Penha-Gonçalves, and Hatem Masmoudi, “Contribution of PTPN22, CD28, CTLA-4 and ZAP-70 variants to the risk of type 1 diabetes in Tunisians,” Gene, 2013. View at Publisher · View at Google Scholar
  • Danielle N. Yarde, Kristina Lorenzo-Arteaga, Kevin P. Corley, Monina Cabrera, and Nora E. Sarvetnick, “CD28− CD8+ T cells are significantly reduced and correlate with disease duration in juveniles with type 1 diabetes,” Human Immunology, 2014. View at Publisher · View at Google Scholar
  • Kea Martin, Jens Schreiner, and Alfred Zippelius, “Modulation of APC Function and Anti-Tumor Immunity by Anti-Cancer Drugs,” Frontiers in Immunology, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Nathan A. Holland, Leslie C. Thompson, Achini K. Vidanapathirana, Rahkee N. Urankar, Robert M. Lust, Timothy R. Fennell, and Christopher J. Wingard, “Impact of pulmonary exposure to gold core silver nanoparticles of different size and capping agents on cardiovascular injury,” Particle and Fibre Toxicology, vol. 13, no. 1, 2016. View at Publisher · View at Google Scholar
  • Katrin Lorenz, Sabine Beck, Munir M. Keilani, Joanna Wasielica-Poslednik, Norbert Pfeiffer, and Franz H. Grus, “Longitudinal Analysis of Serum Autoantibody-Reactivities in Patients with Primary Open Angle Glaucoma and Optic Disc Hemorrhage,” Plos One, vol. 11, no. 12, pp. e0166813, 2016. View at Publisher · View at Google Scholar